Clinical Trial: A Prospective, Randomized, Self-Controlled Clinical Trial of Mesenchymal Stem Cell-Derived Exosomes Combined With Ablative Fractional CO₂ Laser for the Treatment of Striae Distensae (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Randomized, Self-Controlled Clinical Trial of Mesenchymal Stem Cell-Derived Exosomes Combined With Ablative Fractional CO₂ Laser for the Treatment of Striae Distensae'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129893

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Shanghai Putuo District Maternity and Infant Health Care Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=315265

Published by HT Digital Content Services with permission from Health Daily Digest....